Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice.
Gould NL, Scherer GR, Carvalho S, Shurrush K, Kayyal H, Edry E, Elkobi A, David O, Foqara M, Thakar D, Pavesi T, Sharma V, Walker M, Maitland M, Dym O, Albeck S, Peleg Y, Germain N, Babaev I, Sharir H, Lalzar M, Shklyar B, Hazut N, Khamaisy M, Lévesque M, Lajoie G, Avoli M, Amitai G, Lefker B, Subramanyam C, Shilton B, Barr H, Rosenblum K. Gould NL, et al. Among authors: peleg y. J Clin Invest. 2023 Oct 2;133(19):e162120. doi: 10.1172/JCI162120. J Clin Invest. 2023. PMID: 37561584 Free PMC article.
Complex biophysical changes and reduced neuronal firing in an SCN8A variant associated with developmental delay and epilepsy.
Quinn S, Zhang N, Fenton TA, Brusel M, Muruganandam P, Peleg Y, Giladi M, Haitin Y, Lerche H, Bassan H, Liu Y, Ben-Shalom R, Rubinstein M. Quinn S, et al. Among authors: peleg y. Biochim Biophys Acta Mol Basis Dis. 2024 Jun;1870(5):167127. doi: 10.1016/j.bbadis.2024.167127. Epub 2024 Mar 20. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38519006 Free article.
A concise guide to choosing suitable gene expression systems for recombinant protein production.
Schütz A, Bernhard F, Berrow N, Buyel JF, Ferreira-da-Silva F, Haustraete J, van den Heuvel J, Hoffmann JE, de Marco A, Peleg Y, Suppmann S, Unger T, Vanhoucke M, Witt S, Remans K. Schütz A, et al. Among authors: peleg y. STAR Protoc. 2023 Dec 15;4(4):102572. doi: 10.1016/j.xpro.2023.102572. Epub 2023 Oct 31. STAR Protoc. 2023. PMID: 37917580 Free PMC article. Review.
A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR.
Peri L, Matzov D, Huxley DR, Rainish A, Fierro F, Sapir L, Pfeiffer T, Waterloo L, Hübner H, Peleg Y, Gmeiner P, McCormick PJ, Weikert D, Niv MY, Shalev-Benami M. Peri L, et al. Among authors: peleg y. Nat Commun. 2024 Nov 18;15(1):9991. doi: 10.1038/s41467-024-54157-6. Nat Commun. 2024. PMID: 39557861 Free PMC article.
His-tag based supramolecular biopolymerization.
Lal M, Kesselman E, Wachtel E, Kleinerman O, Peleg Y, Albeck S, Majhi K, Sheves M, Patchornik G. Lal M, et al. Among authors: peleg y. Sci Rep. 2024 Nov 16;14(1):28332. doi: 10.1038/s41598-024-78647-1. Sci Rep. 2024. PMID: 39550390 Free PMC article.
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. Among authors: peleg y. J Am Soc Nephrol. 2024 Oct 16. doi: 10.1681/ASN.0000000520. Online ahead of print. J Am Soc Nephrol. 2024. PMID: 39431468 No abstract available.
120 results